The Msi2 reporter also marked LSCs in chronic myeloid leukemia (Fig. 1l) and in an NPM1-driven model of myeloproliferative disease (Fig. 1m). This evidence concerns the gene NPM1 and chronic myelogenous leukemia, BCR-ABL1 positive.